miR-142-3p regulates autophagy by targeting ATG16L1 in thymic-derived regulatory T cell (tTreg)

Yunjie Lu, Ji Gao, Shaopeng Zhang, Jian Gu, Hao Lu, Yongxiang Xia, Qin Zhu, Xiaofeng Qian, Feng Zhang, Chuanyong Zhang, Hongbing Shen, Keli L. Hippen, Bruce R. Blazar, Ling Lu, Xuehao Wang

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Thymic-derived regulatory T cell (tTreg) clinical trials show therapeutic promise in the prevention of acute graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation patients. However, strategies are needed to improve tTreg proliferative ability and survival as a means to improve tTreg therapy and reduce the requirement for producing large numbers of Treg cells for adoptive tTreg transfer. Autophagy is a self-degradative process for cytosolic components, which is involved in cells death, differentiation, lymphocyte homeostasis, and tTreg function. Studies have shown that mice with tTreg cells that have a disrupted autophagy process have defective tTreg cell generation and function, resulting in autoimmune disease and failed GVHD prevention by adoptively transferred tTreg cells. We found the attenuated autophagy status during ex vivo expansion, which leads us to determine whether tTreg cell survival could be augmented by miR-142-3p, the miRNA which is highly expressed in tTreg cells and potentially targets autophagy-related protein (ATG)-1, ATG16L1. We demonstrate that miR-142-3p downregulates ATG16L1 mRNA and production of ATG16L1, that has been linked to autoimmune diseases. Conversely, miR-142-3p knock-down improved tTreg cell expansion, survival and function in vitro and vivo. In aggregate, these studies provide a new approach that uses miR-142-3p knockdown to increase tTreg cell efficacy by increasing ATG16L1 mRNA and protein and the autophagy process.

Original languageEnglish (US)
Pages (from-to)290
Number of pages1
JournalCell death & disease
Volume9
Issue number3
DOIs
StatePublished - Feb 19 2018

Bibliographical note

Funding Information:
This work was also supported in part by Major Program of National Natural Science Fund (81530048, 81571564, 81571557, 81571559, 81521004), Priority Academic Program Development of Jiangsu Higher Education Institutions Fund, Jiangsu Province Youth Found (BK20151021) in China. This work was supported in part by NIH R01 HL11879 from the National Institutes of Health.

Fingerprint Dive into the research topics of 'miR-142-3p regulates autophagy by targeting ATG16L1 in thymic-derived regulatory T cell (tTreg)'. Together they form a unique fingerprint.

Cite this